Literature DB >> 14074393

STRUCTURE OF TYPE 5 ADENOVIRUS. I. ANTIGENIC RELATIONSHIP OF VIRUS-STRUCTURAL PROTEINS TO VIRUS-SPECIFIC SOLUBLE ANTIGENS FROM INFECTED CELLS.

W C WILCOX, H S GINSBERG.   

Abstract

Type 5 adenovirus was purified by fluorocarbon (freon 113) treatment followed by banding in a CsCl equilibrium density gradient. This method permitted separation of virus from normal host cell materials and virus-specific soluble antigens. Virus banded in CsCl with a mean bouyant density of 1.3349 gm/cm(3). The three virus-specific soluble antigens (group- and type-specific antigens and toxin) banded together with a mean bouyant density of 1.2832 gm/cm(3). The group-specific antigen was the predominant antigen of the purified virus particle, whereas the group- and type-specific antigens were present in equal titers in the antigen band. Infectious virus particles were inactivated by prolonged dialysis at pH 10.5. Centrifugation of inactivated virus preparations in a CsCl equilibrium density gradient resulted in separation of virus DNA from specific antigen: the antigens banded with a mean bouyant density of 1.2832 gm/cm(3) and the DNA sedimented to the bottom of the tube. The predominant antigen derived from purified virus particles was the group-specific antigen and it was in the same relative proportion to the type-specific antigen as measured in intact particles. The antigens derived from disrupted virus were immunologically identical with the soluble virus antigens present in infected cells.

Entities:  

Keywords:  ADENOVIRUS; ANTIGENS; DNA, VIRAL; VIRAL PROTEINS

Mesh:

Substances:

Year:  1963        PMID: 14074393      PMCID: PMC2137710          DOI: 10.1084/jem.118.2.295

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD).

Authors:  H S GINSBERG; G F BADGER; J H DINGLE; W S JORDAN; S KATZ
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

2.  Protein synthesis in type 5 adenovirus-infected cells. Effect of p-flourophenylalanine on synthesis of protein. nucleic acids, and infectious virus.

Authors:  W C WILCOX; H S GINSBERG
Journal:  Virology       Date:  1963-06       Impact factor: 3.616

3.  Isodensity ultracentrifugation of foot-and-mouth disease virus in caesium chloride.

Authors:  R TRAUTMAN; S S BREESE
Journal:  J Gen Microbiol       Date:  1962-02

4.  Studies on the biosynthesis of viral DNA.

Authors:  M GREEN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

5.  Antigenic structure of non-infectious adenovirus materials.

Authors:  H G PEREIRA
Journal:  Nature       Date:  1960-05-14       Impact factor: 49.962

6.  Study of adenovirus antigens fractionated by chromatography on DEAE-cellulose.

Authors:  H G KLEMPERER; H G PEREIRA
Journal:  Virology       Date:  1959-12       Impact factor: 3.616

7.  Recovery of new agent from patients with acute respiratory illness.

Authors:  M R HILLEMAN; J H WERNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-01

8.  EQUILIBRIUM SEDIMENTATION OF MACROMOLECULES IN DENSITY GRADIENTS.

Authors:  M Meselson; F W Stahl; J Vinograd
Journal:  Proc Natl Acad Sci U S A       Date:  1957-07-15       Impact factor: 11.205

9.  STRUCTURE OF TYPE 5 ADENOVIRUS. II. FINE STRUCTURE OF VIRUS SUBUNITIS. MORPHOLOGIC RELATIONSHIP OF STRUCTURAL SUBUNITS TO VIRUS-SPECIFIC SOLUBLE ANTIGENS FROM INFECTED CELLS.

Authors:  W C WILCOX; H S GINSBERG; T F ANDERSON
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

  9 in total
  21 in total

1.  Hexon peptides of type 2, 3, and 5 adenoviruses and their relationship to hexon structure.

Authors:  M F Stinski; H S Ginsberg
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Potency of adenovirus vaccines: comparison of unconcentrated, concentrated, and soluble antigen preparations.

Authors:  R R Strauss; N R Goulet; O C Liu; J M Beiler
Journal:  Appl Microbiol       Date:  1966-11

3.  Characterization of a temperature-sensitive, hexon transport mutant of type 5 adenovirus.

Authors:  R S Kauffman; H S Ginsberg
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

4.  Identification of the adenovirus components during the penetration in HeLa cells by immunofluorescence technique.

Authors:  Y Chardonnet; M Lyon; A Soula
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  Activity of aspartate transcarbamylase in uninfected and type 5 adenovirus-infected HeLa cells.

Authors:  R A Consigli; H S Ginsberg
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

6.  Role of adenovirus structural proteins in the cessation of host-cell biosynthetic functions.

Authors:  A J Levine; H S Ginsberg
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

7.  Experimental adenovirus immune complex glomerulonephritis.

Authors:  N G Wright; W I Morrison; H Thompson; H J Cornwell
Journal:  Br J Exp Pathol       Date:  1973-12

8.  Mechanism by which fiber antigen inhibits multiplication of type 5 adenovirus.

Authors:  A J Levine; H S Ginsberg
Journal:  J Virol       Date:  1967-08       Impact factor: 5.103

9.  Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid.

Authors:  W C Lawrence; H S Ginsberg
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Cleavage by formamide of intercapsomer bonds in adenovirus types 4 and 7 virions and hemagglutinins.

Authors:  A R Neurath; B A Rubin; J T Stasny
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.